A new study finds that using the ISBAR communication model significantly improves bedside care quality among rheumatology and immunology nurses, supporting wider adoption in clinical handoffs.

Fresenius Kabi Canada announces that its tocilizumab biosimilar Tyenne® referencing Actemra®** (tocilizumab) is now commercially available in Canada. Tyenne® is the first and only tocilizumab ...

The updated recommendations also provide guidance on antirheumatic drug use through lactation and in male patients trying to ...

WILLOW is a global, multicenter, randomized, placebo-controlled Phase 2 study evaluating three doses of enpatoran taken twice daily (25 mg, 50 mg and 100 mg) versus placebo plus standard of care (SoC) ...

Resources are available to help physicians when they encounter variants of unknown significance during genetic testing, Troy ...

The trial is being conducted by Integral Rheumatology & Immunology Specialists (IRIS), in an outpatient setting at a ...

Cohort analyses from the WILLOW study reveal clear proof of concept in patients with CLE and SLE with active lupus rash, showing clinically meaningful ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is ...

Margrit Wiesendanger, MD, PhD, explores lupus symptoms, diagnosis challenges, and the importance of early detection to prevent inflammation-related damage.

Researchers previously characterized calprotectin’s utility as a biomarker in overtly inflammatory disorders like COVID-19, ...

The twist comes ahead of the show’s first season finale. Based on Sir Arthur Conan Doyle ‘s Sherlock Holmes stories, Watson takes place six months after Moriarty killed the legendary detective.

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...